Skip to main content
Clinical Trials/DRKS00022091
DRKS00022091RecruitingNot Applicable

Blood brain barrier permeability and inflammatory biomarkers in patients with depression - DEFLAME

Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt0 sites100 target enrollmentStarted: July 6, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 55 Years (—)
Sex
All

Inclusion Criteria

  • - Presence of a severe single or recurrent depressive disorder with or without psychotic symptoms (according to ICD 10: F32.2, F32.3, F33.2, F33.3)
  • - ability to give consent
  • Healthy controls:
  • - Ability to give consent

Exclusion Criteria

  • - Presence of a severe somatic or neurological disease
  • - Pregnancy and breastfeeding
  • Healthy controls:
  • - Presence of a psychiatric, severe somatic or neurological disease
  • - Pregnancy and breastfeeding

Investigators

Sponsor
Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt

Similar Trials

Blood brain barrier permeability and... | Clinical Trial